pharmaCline Partners with The Balancing Act on Lifetime Television

pharmaCline, an innovative pharmaceutical company is partnering with The Balancing Act on Lifetime Television in a four part mini-series to discuss First Aid Wound Care for every member of your family.

Sioux Falls, SD, March 24, 2012 --(PR.com)-- pharmaCline®, a South Dakota pharmaceutical company, draws a national spotlight as it partners with Brandstar Entertainment’s hit morning show “The Balancing Act” on Lifetime Television. The first episode of a four-part mini-series aired March 20, 2012, and featured pharmaCline CEO Steve Keough, who discussed the basics of first aid wound care and infection control.

At least 50 million Americans are at an increased risk of infection from minor cuts, scrapes, and burns. This includes diabetics, pre-diabetics, smokers, people taking immuno-compromising medications, the elderly and others. “Our goal during these shows is to increase the practical knowledge of caregivers for these at-risk loved ones,” said Keough.

The miniseries will also cover:

Caring For Your Loved One- Diabetic Wound Care, April 16th,2012
Wound and Disease Prevention for the Elderly, May 14th, 2012
Medicine Cabinet makeover, August 2012.

pharmaCline’s adoption of game changing drug delivery technologies has led to high value prescription and over-the-counter product pipelines. pharmaCline’s Diabecline® OTC antibiotic is among the final four pharmaceutical products vying for the 2012 Best New Pharmaceutical Product in this year’s prestigious Edison Awards.

“pharmaCline’s unique products enable more people to embrace healing,” said Keough, “and we are pleased to collaborate with “The Balancing Act” on Lifetime Television in this important awareness campaign.”

Contact Information:
Lana McCoy, Executive Marketing Coordinator
Email: lmccoy(at)pharmacline.com
Phone: 605-271-2086
2329 N. Career Avenue, Suite 243
Sioux Falls, SD 57107
www.pharmacline.com
Contact
pharmaCline
Lana McCoy
605-271-2086
www.pharmacline.com
ContactContact
Categories